Clinical Trial Update: Divalproex ER vs. Risperidone for Bipolar Disorder With Comorbid Substance Use Disorder [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing divalproex ER and risperidone for bipolar disorder with comorbid substance use disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Substance Use Disorder

Drugs mentioned

• Divalproex ER (divalproex sodium)
• RISPERIDONE (RISPERIDONE)

Snippet

Sponsor: Tuscaloosa Research & Education Advancement Corporation | Conditions: Substance Abuse, Bipolar Depression | Phase 4 | Status: COMPLETED